Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00476177
Recruitment Status : Completed
First Posted : May 21, 2007
Last Update Posted : March 29, 2012
Brigham and Women's Hospital
Beth Israel Deaconess Medical Center
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Edwin P. Alyea, MD, Dana-Farber Cancer Institute

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2007
  Actual Study Completion Date : July 2009